Last reviewed · How we verify
hydrocortisone plus fludrocortisone
hydrocortisone plus fludrocortisone is a Small molecule drug developed by Centre Hospitalier Universitaire, Amiens. It is currently FDA-approved. Also known as: Hydrocortisone Injection, Fludrocortisone Acetate Tablets.
Hydrocortisone plus fludrocortisone is used to treat septic shock, according to a prospective randomized controlled clinical trial. The combination of hydrocortisone and fludrocortisone is also studied for other conditions, including adrenal insufficiency, but the specific indications for this combination are not specified in the provided facts.
At a glance
| Generic name | hydrocortisone plus fludrocortisone |
|---|---|
| Also known as | Hydrocortisone Injection, Fludrocortisone Acetate Tablets |
| Sponsor | Centre Hospitalier Universitaire, Amiens |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004) (PHASE3)
- Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003) (PHASE3)
- A Study of Opevesostat (MK-5684) in China Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (MK-5684-001) (PHASE1)
- A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015) (PHASE2)
- A Study of Opevesostat (MK-568)4 in Japanese Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-005) (PHASE1)
- Adjunctive Fludrocortisone in Septic Shock (PHASE2)
- Hydrocortisone and Fludrocortisone for the Treatment of Septic Shock (PHASE4)
- Platform of Randomized Adaptive Clinical Trials in Critical Illness (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- hydrocortisone plus fludrocortisone CI brief — competitive landscape report
- hydrocortisone plus fludrocortisone updates RSS · CI watch RSS
- Centre Hospitalier Universitaire, Amiens portfolio CI
Frequently asked questions about hydrocortisone plus fludrocortisone
What is hydrocortisone plus fludrocortisone?
Who makes hydrocortisone plus fludrocortisone?
Is hydrocortisone plus fludrocortisone also known as anything else?
What development phase is hydrocortisone plus fludrocortisone in?
Related
- Manufacturer: Centre Hospitalier Universitaire, Amiens — full pipeline
- Also known as: Hydrocortisone Injection, Fludrocortisone Acetate Tablets
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing